Skip to main content
Log in

Vergleich von vier Behandlungsoptionen beim Prostatakarzinom mit niedrigem Risiko

Präferenzbasierte randomisierte Studie zur Evaluation von vier Behandlungsmodalitäten beim Prostatakarzinom mit niedrigem oder „frühem intermediären“ Risiko (PREFERE) – Studie AP 65/11 der AUO

Comparison of four treatment options for low-risk prostate cancer

Preference-based randomized study for the evaluation of four treatment modalities in prostate cancer with low or “early intermediate” risk (PREFERE) – trial AP 65/11 of the AUO

  • AUO
  • Published:
Der Urologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Bussar-Maatz.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rexer, H., Bussar-Maatz, R. Vergleich von vier Behandlungsoptionen beim Prostatakarzinom mit niedrigem Risiko. Urologe 54, 723–725 (2015). https://doi.org/10.1007/s00120-015-3816-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-015-3816-1

Navigation